Brief: Rhythm Pharmaceuticals Q1 Net Income USD -141.372 Million
07/05/2024 12:00
May 07 (Reuters) - Rhythm Pharmaceuticals Q1 operating income USD -139.887 million. * Q1 product revenue USD 25.967 million * Q1 basic EPS USD -2.35
Recent news on Rhythm Pharmaceuticals
See all newsBrief: Rhythm Pharmaceuticals Announces Appointment Of Manher (Aj) Joshi As Chief Medical Officer
Rhythm's drug shows promise for brain tumor-related weight condition in small study (updated)
Rhythm Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Rhythm Pharma's obesity drug shows promise for brain tumor-related weight condition
Rhythm Pharmaceuticals Q2 net loss narrows on US launch demand